Pharmacokinetic Study of E7080/Lenvatinib in Chinese Subjects With Solid Tumor
NCT03009292
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumor
Interventions
DRUG:
lenvatinib
Sponsor
Eisai Co., Ltd.